Complement involvement in kidney diseases: From physiopathology to therapeutical targeting

doi:10.5527/wjn.v4.i2.169

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10855)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

653

WORD

355

HTML

6672

Figures (1-4)

445

Tables (1-3)

360

Sum=8485

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

979

Download

1391

Sum=2370

May 6, 2015 (publication date) through Mar 6, 2025

Times Cited of This Article

Times Cited (15)

Journal Information of This Article

Publication Name

World Journal of Nephrology

ISSN

2220-6124

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Nephrol. May 6, 2015; 4(2): 169-184
Published online May 6, 2015. doi: 10.5527/wjn.v4.i2.169

Full Size Figure Download Figure

Figure 3 Dysregulation of the alternative complement cascade due to acquired or genetic factors leads to defective complement control causing a range of complement-associated glomerulopathies. CFHR3: Complement factor H-related protein 3; MCP: Membrane co-factor protein; CR1: Complement receptor 1; AP: Alternative pathway; CFHR5: Complement factor H-related protein 5; FSGS: Focal segments glomerular sclerosis; MAC: Membrane attack complex.

Citation: Salvadori M, Rosso G, Bertoni E. Complement involvement in kidney diseases: From physiopathology to therapeutical targeting. World J Nephrol 2015; 4(2): 169-184
URL: https://www.wjgnet.com/2220-6124/full/v4/i2/169.htm
DOI: https://dx.doi.org/10.5527/wjn.v4.i2.169